TPD & Induced Proximity Summit Leaderboard
  • Friday, July 3, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Page 889

Russian Federation approves multi-dosage cGMP certificate to Saneca Pharma

May 18, 2017
Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

SystImmune selects MilliporeSigma’s CHOZN Expression System for Bi-specific Antibody Development

May 18, 2017
MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

AVEO Oncology appoints Matthew Dallas as CFO

May 18, 2017
AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Invests $2.4M to increase Pilot Scale Capacity at its High Point facility

May 18, 2017
Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...

Halo Pharma announces the Formation of its Pediatric Center of Excellence

May 18, 2017
Halo Pharma announces the formation of its Pediatric Center of Excellence in support of the development and manufacture of dosage forms tailored for pediatric indications. Halo Pharma…
Read More...

BMS and Calithera Biosciences expand collaboration to evaluate Opdivo combined with CB-839 on NSCLC…

May 18, 2017
Bristol-Myers Squibb (BMS) and Calithera Biosciences expanded their collaboration to evaluate BMS’s Opdivo in combination with Calithera’s CB-839 in patients with non-small cell lung…
Read More...

Noxxon Pharma signs collaboration with NCT in Heidelberg

May 17, 2017
NOXXON Pharma signed an agreement with the National Center for Tumor Diseases (NCT) in Heidelberg. Under the agreement NCT will conduct a trial evaluating NOXXON’s lead product…
Read More...

Helen Milton appointed AMAG’s Regulatory Affairs Vice President

May 17, 2017
AMAG Pharmaceuticals announced that Helen Milton has been appointed as AMAG's Regulatory Affairs vice president. She will be responsible for regulatory activities along with company’s…
Read More...

Synlogic and Mirna Therapeutics signs definitive merger

May 17, 2017
Synlogic announced that it has entered into a definitive merger agreement with a wholly owned subsidiary of Mirna in an all-stock transaction and will continue under the Synlogic name.…
Read More...

Catalent pharma collaborate with Therachon for development of TA-46

May 16, 2017
Catalent Pharma Solutions announced that it has collaborated with Therachon AG to support preclinical and clinical development of TA-46. TA-46 is a novel protein addressing…
Read More...
Previous 1 … 887 888 889 890 891 … 936 Next
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Zymeworks to Acquire Theravance Biopharma in $929 Million Deal
  • EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia
  • Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal
  • AstraZeneca, YMCA Launch National Cancer Education Partnership
  • Antares, Novartis Partner on Cancer Drug Discovery

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.